Place conditioning of mice with the NMDA receptor antagonists, eliprodil and dizocilpine

European Journal of Pharmacology

Volumn 362, Issue 2-3, 1998, Pages 103-110

  Sukhotina, Irina ^a   Dravolina, Olga ^a   Bespalov, Anton ^a  

^a PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Dizocilpine; Eliprodil; Mouse; NMDA receptor antagonist; Place conditioning; Social interaction

Indexed keywords

DIZOCILPINE; ELIPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONDITIONING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; SOCIAL INTERACTION;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; HOUSING, ANIMAL; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED STRAINS; PIPERIDINES; RECEPTORS, N-METHYL-D-ASPARTATE; SOCIAL ENVIRONMENT; STRESS;

EID: 0032423286     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00737-7     Document Type: Article

References (34)

1. Acquas E., Carboni E., Leone P., Di Chiara G. SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Psychopharmacology. 99:1989;151-155.
2. Avenet P., Leonardon J., Besnard F., Graham D., Depoortere H., Scatton B. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes. Neurosci. Lett. 223:1997;133-136.
3. Balster, R.L., Willetts, J., 1996. Phencyclidine: a drug of abuse and a tool for neuroscience research. In: Schuster, C.R., Kuhar, M.J. (Eds.), Pharmacological Aspects of Drug Dependence: Towards an Integrated Neurobehavioral Approach, Handbook of Experimental Pharmacology, Vol. 118. Springer-Verlag, Berlin, pp. 233-262.
4. Balster R.L., Nicholson K.L., Sanger D.J. Evaluation of the reinforcing effects of eliprodil in rhesus monkeys and its discriminative stimulus effects in rats. Drug Alcohol Depend. 35:1994;211-216.
5. Bardo et al., 1986.
6. Beaman C.M., Hunter G.A., Reid L.D. Diprenorphine, an antagonist of opioid analgesia, elicits a positive affective state in rats. Bull. Psychonom. Soc. 22:1984;354-355.
7. Bespalov, A.Yu., Tokarz, M.E., Bowen, S.E., Beardsley, P.M., Balster, R.L. Effects of test conditions on the outcome of place conditioning with morphine and naltrexone in mice, Psychopharmacology, in press.
8. Carr G.D., Phillips A.G., Fibiger H.C. Independence of amphetamine reward from locomotor stimulation demonstrated by conditioned place preference. Psychopharmacology. 94:1988;221-226.
9. Cunningham C.L., Noble D. Methamphetamine-induced conditioned place preference or aversion depending on dose and presence of drug. Ann. New York Acad. Sci. 654:1992;431-433.
10. Del Pozo E., Barrios M., Baeyens J.M. The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine induced place preference conditioning in mice. Psychopharmacology. 125:1996;209-213.
11. Elliott P.J. Place aversion induced by the substance P analogue, dimethyl-C7, is not state dependent: implication of substance P in aversion. Exp. Brain Res. 73:1988;354-356.
12. Gauvin D.V., Dormer K.N., Holloway F.A. Pentylenetetrazole can induce a conditioned place preference. Pharmacol. Biochem. Behav. 40:1991;987-990.
13. Hiroi N., White N.M. The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas. Brain Res. 552:1991;141-152.
14. Hoffman D.C. The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats. Pharmacol. Biochem. Behav. 47:1994;907-912.
15. Iwamoto E.T. Place-aversion conditioned by phencyclidine in rats: development of tolerance and pharmacologic antagonism. Alcohol Drug Res. 6:1986;265-276.
16. Jackson A., Sanger D.J. Conditioned taste aversions induced by phencyclidine and other antagonists of N-methyl-D-aspartate. Neuropharmacology. 28:1989;459-464.
17. Kitaichi K., Noda Y., Hasegawa T., Furukawa H., Nabeshima T. Acute phencyclidine induces aversion, but repeated phencyclidine induces preference in the place conditioning test in rats. Eur. J. Pharmacol. 318:1996;7-9.
18. Layer R.T., Kaddis F.G., Wallace L.J. The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats. Pharmacol. Biochem. Behav. 44:1993;245-247.
19. Layer R.T., Popik P., Olds T., Skolnick P. Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715). Pharmacol. Biochem. Behav. 52:1995;621-627.
20. Marglin S.H., Milano W.C., Mattie M.E., Reid L.D. PCP and conditioned place preferences. Pharmacol. Biochem. Behav. 33:1989;281-283.
21. Martin-Iverson M.T., Reimer A.R., Sharma S. Unbiased cocaine conditioned place preferences (CPP) obscures conditioned locomotion, and nimodipine blockade of cocaine CPP is due to conditioned place aversions. Psychopharmacology. 130:1997;327-333.
22. Miczek K.A., Winslow J.T. Analgesia and decrement in operant performance in socially defeated mice: selective cross-tolerance to morphine and antagonism by naltrexone. Psychopharmacology. 92:1987;444-451.
23. Oberling P., Rocha B., Di Scala G., Sandner G. Evidence for state-dependent retrieval in conditioned place aversion. Behav. Neural Biol. 60:1993;27-32.
24. Panconi E., Roux J., Altenbaumer M., Hampe S., Porsolt R.D. MK-801 and enantiomers: potential antidepressants or false positives in classical screening models? Pharmacol. Biochem. Behav. 46:1993;15-20.
25. Papp M., Moryl E. Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression. Eur. J. Pharmacol. 263:1994;1-7.
26. Papp M., Moryl E., Maccecchini M.L. Differential effects of agents acting at various sites of the NMDA receptor complex in a place preference conditioning model. Eur. J. Pharmacol. 317:1996;191-196.
27. Patat A., Molinier P., Hergueta T., Brohier S., Zieleniuk I., Danjou P., Warot D., Puech A. Lack of amnestic, psychotomimetic or impairing effect on psychomotor performance of eliprodil, a new NMDA antagonist. Int. Clin. Psychopharmacol. 9:1994;155-162.
28. Poshivalov, V.P., Verbitskaya, E.V., 1989. Pain and depression: ethopharmacological analysis. In: Ignatov, Yu.D. (Ed.), Drug-induced Analgesia. PMI, Leningrad, pp. 124-132.
29. Sanger D.J., Jackson A. Effects of phencyclidine and other N-methyl-D-aspartate antagonists on the schedule-controlled behavior of rats. J. Pharmacol. Exp. Ther. 248:1989;1215-1221.
30. Steinpreis R.E., Kramer M.A., Mix K.S., Piwowarczyk M.C. The effects of MK801 on place conditioning. Neurosci. Res. 22:1995;427-430.
31. Swerdlow N.R., van der Kooy D., Koob G.F., Wenger J.R. Cholecystokinin produces conditioned place-aversions, not place-preferences, in food-deprived rats: evidence against involvement in satiety. Life Sci. 32:1983;2087-2093.
32. Verbitskaya E.V. The influence of chronic administration of antidepressants on timid-defensive behavior in mice. Eur. J. Neurosci. S. 5:1992;308.
33. Wong E.H., Kemp J.A., Priestly T., Knight A.R., Woodruff G.N., Iversen L.L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA. 83:1986;7104-7108.
34. Wongwitdecha N., Marsden C.A. Isolation rearing prevents the reinforcing properties of amphetamine in a conditioned place preference paradigm. Eur. J. Pharmacol. 279:1995;99-103.